Discovery Fueled by Ultra-Sensitivity
Quanterix is at the forefront of biotechnology research, driving advancements in precision health through the digitization of biomarker analysis. With its ultra-sensitive Simoa technology, Quanterix is transforming healthcare by enabling researchers to explore the role of biomarkers across the health-disease continuum. This innovative approach facilitates earlier disease detection, enhanced prognosis, and the development of precise treatment methods, ultimately improving the quality of life and longevity for future generations.
Located at 900 Middlesex Tpke, Billerica, Massachusetts 01821, US, Quanterix is dedicated to pioneering new solutions in oncology, neurology, cardiology, inflammation, and infectious diseases. The company’s commitment to innovation ensures that Quanterix remains a leader in providing cutting-edge tools for researchers and healthcare professionals alike. The groundbreaking work conducted by Quanterix continues to shape the future of medical science and patient care.
We invite the management team at Quanterix to take the next step in showcasing their leadership by creating a customized and exclusive company showcase and product listing on our platform. This will further amplify Quanterix's visibility and impact within the biotechnology research community.
Quanterix est à l'avant-garde de la recherche biotechnologique, stimulant les progrès en matière de santé de précision grâce à la numérisation de l'analyse des biomarqueurs. Grâce à sa technologie Simoa ultra-sensible, Quanterix transforme les soins de santé en permettant aux chercheurs d'explorer le rôle des biomarqueurs dans le continuum santé-maladie. Cette approche innovante facilite la détection précoce des maladies, l'amélioration du pronostic et le développement de méthodes de traitement précises, améliorant ainsi la qualité de vie et la longévité des générations futures.
Située au 900 Middlesex Tpke, Billerica, Massachusetts 01821, États-Unis, Quanterix se consacre à la création de nouvelles solutions en oncologie, neurologie, cardiologie, inflammation et maladies infectieuses. L'engagement de l'entreprise envers l'innovation garantit que Quanterix reste un chef de file dans la fourniture d'outils de pointe aux chercheurs et aux professionnels de la santé. Le travail novateur mené par Quanterix continue de façonner l'avenir de la science médicale et des soins aux patients.
Nous invitons l'équipe de direction de Quanterix à passer à l'étape suivante en présentant son leadership en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme. Cela amplifiera encore la visibilité et l'impact de Quanterix au sein de la communauté de la recherche biotechnologique.
Compare Quanterix with 3 companies in Biotechnology-Research
| Comparison Field |
QuanterixMain Company |
Juncker LabView Profile |
OncoSeer Diagnostics...View Profile |
Kiffik Biomedical, I...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2005 | 2022 | 2021 |
|
Company Size
|
— | 11-50 | 2-10 | 11-50 |
|
City
|
Billerica, Massachusetts | Montreal, Quebec | Dallas, Texas | Providence, Rhode Island |
|
Country
|
United States | Canada | United States | United States |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Biotechnology
Biomarker Analysis
Precision Health
Simoa Technology
Disease Detection
Medical Research
Healthcare Solutions
oncology
ultrasensitive immunoassay
assays
neurology
diagnostics
biomarkers
digital ELISA
proteomics
|
10 Total
10 Unique
Unique Skills:
3D printing
bioengineering
biomedical engineering
cell culture
exosomes
microfluidics
+4
|
5 Total
5 Unique
Unique Skills:
AI/ML
autoimmune toxicity
cancer
immune checkpoint inhibitors
Immunology
|
8 Total
8 Unique
Unique Skills:
aging
cancer
cardiometabolic
clinical trial
interstitial fluid
neurocognitive
+2
|
Other organizations in the same industry
This company is also known as